查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1448825

全球肿瘤学人工智慧市场研究报告 - 2024 年至 2032 年行业分析、规模、份额、成长、趋势和预测

Global AI In Oncology Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032
出版日期: | 出版商: Value Market Research | 英文 293 Pages | 商品交期: 最快1-2个工作天内

价格

全球肿瘤市场人工智慧需求预计将从 2023 年的 40.2 亿美元达到近 93 亿美元的市场规模，2024 年至 2032 年研究期间CAGR为 9.77%。

肿瘤学中的人工智慧涉及在癌症诊断、治疗计划和研究中使用人工智慧 (AI)，例如机器学习演算法。人工智慧工具分析大量医疗资料，包括影像研究、遗传资讯和临床记录，以帮助医疗保健专业人员做出更精确和个人化的决策。这些技术可以增强早期癌症检测、预测治疗结果并推荐客製化疗法。肿瘤学人工智慧有望改善患者治疗结果、优化治疗策略并增进我们对癌症生物学的理解。

市场动态

癌症诊断和治疗决策日益复杂，推动了肿瘤学市场的人工智慧发展，导致肿瘤学对人工智慧 (AI) 解决方案的依赖日益增加。包括机器学习和影像分析在内的人工智慧应用可帮助医疗保健专业人员解读医学影像、识别生物标记和製定个人化治疗计划。大量的肿瘤资料，加上对精准医疗的需求，推动了人工智慧在肿瘤学领域的应用。提高诊断准确性、预测治疗反应和优化患者治疗结果的能力有助于市场成长。此外，科技公司与医疗机构之间的合作以及对基于人工智慧的医疗解决方案的监管支持进一步推动了肿瘤市场的人工智慧。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具也对全球肿瘤学人工智慧市场的各个细分市场进行了包容性评估。人工智慧在肿瘤学行业的成长和趋势为这项研究提供了整体方法。

市场区隔

肿瘤学人工智慧市场报告的这一部分提供了国家和区域层面细分市场的详细资料，从而帮助策略家确定相应产品或服务的目标人群以及即将到来的机会。

依组件类型

  • 软体解决方案
  • 硬体
  • 服务

按癌症类型

  • 乳癌
  • 肺癌
  • 摄护腺癌
  • 大肠直肠癌
  • 脑肿瘤
  • 其他的

按应用

  • 诊断（病理学、癌症放射学）
  • 放射治疗（放射治疗）
  • 研究与开发（药物设计、开发流程等）
  • 化疗
  • 免疫疗法

依最终用途类型

  • 医院
  • 外科中心和医疗机构
  • 其他（製药公司、研究所和培训中心）

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲肿瘤学人工智慧市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。肿瘤学人工智慧市场的主要参与者包括 Azra AI、IBM、西门子医疗有限公司、英特尔公司、GE HealthCare、Nvidia 公司、Digital Diagnostics Inc.、ConcertAI、Median Technologies、PathAI。本节包含竞争格局的整体视图，包括各种策略发展，例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

目录

第一章：前言

  • 报告说明
    • 客观的
    • 目标受众
    • 独特的销售主张 (USP) 和产品
  • 研究范围
  • 研究方法论
    • 市场研究过程
    • 市场研究方法论

第 2 章：执行摘要

  • 市集亮点
  • 全球市场概况

第 3 章：肿瘤学中的人工智慧 - 产业分析

  • 简介 - 市场动态
  • 市场驱动因素
  • 市场限制
  • 机会
  • 产业动态
  • 波特五力分析
  • 市场吸引力分析
    • 按组件类型分類的市场吸引力分析
    • 按癌症类型分類的市场吸引力分析
    • 市场吸引力分析：依应用分类
    • 按最终用途类型分類的市场吸引力分析
    • 市场吸引力分析：按地区

第 4 章：价值链分析

  • 价值链分析
  • 原料分析
    • 原料清单
    • 原料厂商清单
    • 主要原物料价格走势
  • 潜在买家名单
  • 行销管道
    • 直效行销
    • 间接行销
    • 行销通路发展趋势

第 5 章：全球肿瘤学人工智慧市场分析：按组成部分类型

  • 按组件类型概述
  • 历史和预测数据
  • 依组件类型分析
  • 软体解决方案
  • 硬体
  • 服务

第 6 章：全球肿瘤学人工智慧市场分析：按癌症类型

  • 按癌症类型概述
  • 历史和预测数据
  • 按癌症类型分析
  • 乳癌
  • 肺癌
  • 摄护腺癌
  • 大肠直肠癌
  • 脑肿瘤
  • 其他的

第 7 章：全球肿瘤学人工智慧市场分析：按应用分类

  • 概述：按应用
  • 历史和预测数据
  • 分析：按应用
  • 诊断（病理学、癌症放射学）
  • 放射治疗（放射治疗）
  • 研究与开发（药物设计、开发流程等）
  • 化疗
  • 免疫疗法

第 8 章：全球肿瘤学人工智慧市场分析：按最终用途类型

  • 按最终用途类型分類的概述
  • 历史和预测数据
  • 依最终用途类型分析
  • 医院
  • 外科中心和医疗机构
  • 其他（製药公司、研究所和培训中心）

第 9 章：全球肿瘤学人工智慧市场分析：按地理位置

  • 区域展望
  • 介绍
  • 北美销售分析
    • 概览、历史与预测资料销售分析
    • 北美按细分市场销售分析
    • 北美按国家销售分析
    • 美国销售分析
    • 加拿大销售分析
    • 墨西哥销售分析
  • 欧洲销售分析
    • 概览、历史与预测资料销售分析
    • 欧洲按细分市场销售分析
    • 欧洲按国家销售分析
    • 英国销售分析
    • 法国销售分析
    • 德国销售分析
    • 义大利销售分析
    • 俄罗斯销售分析
    • 欧洲其他地区销售分析
  • 亚太地区销售分析
    • 概览、历史与预测资料销售分析
    • 亚太地区按细分市场销售分析
    • 亚太地区国家/地区销售分析
    • 中国销售分析
    • 印度销售分析
    • 日本销售分析
    • 韩国销售分析
    • 澳洲销售分析
    • 东南亚销售分析
    • 亚太地区其他地区销售分析
  • 拉丁美洲销售分析
    • 概览、历史与预测资料销售分析
    • 拉丁美洲按细分市场销售分析
    • 拉丁美洲按国家销售分析
    • 巴西销售分析
    • 阿根廷销售分析
    • 秘鲁销售分析
    • 智利销售分析
    • 拉丁美洲其他地区销售分析
  • 中东和非洲销售分析
    • 概览、历史与预测资料销售分析
    • 中东和非洲按细分市场销售分析
    • 中东和非洲国家销售分析
    • 沙乌地阿拉伯销售分析
    • 阿联酋销售分析
    • 以色列销售分析
    • 南非销售分析
    • 中东其他地区和非洲销售分析

第 10 章：肿瘤公司人工智慧的竞争格局

  • 人工智慧在肿瘤市场竞争的应用
  • 伙伴关係/协作/协议
  • 併购
  • 新产品发布
  • 其他发展

第 11 章：公司简介

  • 公司股份分析
  • 市场集中度
  • Azra AI
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • IBM
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Siemens Healthcare GmbH
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Intel Corporation
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • GE HealthCare
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Nvidia Corporation
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Digital Diagnostics Inc.
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • ConcertAI
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Median Technologies
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • PathAI
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展

注意 - 在公司概况中，财务详细资讯和近期发展视情况而定，或者如果是私人公司，则可能不包括在内

Product Code: VMR112113824

The global demand for AI In Oncology Market is presumed to reach the market size of nearly USD 9.3 Billion by 2032 from USD 4.02 Billion in 2023 with a CAGR of 9.77% under the study period 2024 - 2032.

AI in Oncology involves using artificial intelligence (AI), such as machine learning algorithms, in cancer diagnosis, treatment planning, and research. AI tools analyze vast amounts of medical data, including imaging studies, genetic information, and clinical records, to assist healthcare professionals in making more precise and personalized decisions. These technologies can enhance early cancer detection, predict treatment outcomes, and recommend tailored therapies. Artificial Intelligence for oncology holds promise for improving patient outcomes, optimizing treatment strategies, and advancing our understanding of cancer biology.

MARKET DYNAMICS

The AI in oncology market is propelled by the increasing complexity of cancer diagnosis and treatment decisions, leading to a growing reliance on artificial intelligence (AI) solutions in oncology. AI applications, including machine learning and image analysis, assist healthcare professionals in interpreting medical images, identifying biomarkers, and personalized treatment plans. The vast amount of oncological data, coupled with the need for precision medicine, drives the adoption of AI in oncology. The ability to enhance diagnostic accuracy, predict treatment responses, and optimize patient outcomes contributes to market growth. Additionally, collaborations between technology companies and healthcare institutions and regulatory support for AI-based medical solutions further boost AI in oncology market.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of ai in oncology. The growth and trends of ai in oncology industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the ai in oncology market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Component Type

  • Software Solutions
  • Hardware
  • Services

By Cancer Type

  • Breast Cancer
  • Lung Cancer
  • Prostate Cancer
  • Colorectal Cancer
  • Brain Tumor
  • Others

By Application

  • Diagnostics (Pathology, Cancer Radiology)
  • Radiation Therapy (Radiotherapy)
  • Research & Development (Drug Design, Development Process, Etc.)
  • Chemotherapy
  • Immunotherapy

By End-Use Type

  • Hospitals
  • Surgical Centers & Medical Institutes
  • Others (Pharmaceutical Companies, Research Institutes & Training Centers)

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the AI In Oncology market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the AI In Oncology market include Azra AI, IBM, Siemens Healthcare GmbH, Intel Corporation, GE HealthCare, Nvidia Corporation, Digital Diagnostics Inc., ConcertAI, Median Technologies, PathAI. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . AI IN ONCOLOGY - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Component Type
    • 3.7.2 Market Attractiveness Analysis By Cancer Type
    • 3.7.3 Market Attractiveness Analysis By Application
    • 3.7.4 Market Attractiveness Analysis By End-use Type
    • 3.7.5 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL AI IN ONCOLOGY MARKET ANALYSIS BY COMPONENT TYPE

  • 5.1 Overview by Component Type
  • 5.2 Historical and Forecast Data
  • 5.3 Analysis by Component Type
  • 5.4 Software Solutions Historic and Forecast Sales by Regions
  • 5.5 Hardware Historic and Forecast Sales by Regions
  • 5.6 Services Historic and Forecast Sales by Regions

6 . GLOBAL AI IN ONCOLOGY MARKET ANALYSIS BY CANCER TYPE

  • 6.1 Overview by Cancer Type
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Cancer Type
  • 6.4 Breast Cancer Historic and Forecast Sales by Regions
  • 6.5 Lung Cancer Historic and Forecast Sales by Regions
  • 6.6 Prostate Cancer Historic and Forecast Sales by Regions
  • 6.7 Colorectal Cancer Historic and Forecast Sales by Regions
  • 6.8 Brain Tumor Historic and Forecast Sales by Regions
  • 6.9 Others Historic and Forecast Sales by Regions

7 . GLOBAL AI IN ONCOLOGY MARKET ANALYSIS BY APPLICATION

  • 7.1 Overview by Application
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by Application
  • 7.4 Diagnostics (Pathology, Cancer Radiology) Historic and Forecast Sales by Regions
  • 7.5 Radiation Therapy (Radiotherapy) Historic and Forecast Sales by Regions
  • 7.6 Research & Development (Drug Design, Development Process, etc.) Historic and Forecast Sales by Regions
  • 7.7 Chemotherapy Historic and Forecast Sales by Regions
  • 7.8 Immunotherapy Historic and Forecast Sales by Regions

8 . GLOBAL AI IN ONCOLOGY MARKET ANALYSIS BY END-USE TYPE

  • 8.1 Overview by End-use Type
  • 8.2 Historical and Forecast Data
  • 8.3 Analysis by End-use Type
  • 8.4 Hospitals Historic and Forecast Sales by Regions
  • 8.5 Surgical Centers & Medical Institutes Historic and Forecast Sales by Regions
  • 8.6 Others (Pharmaceutical Companies, Research Institutes & Training Centers) Historic and Forecast Sales by Regions

9 . GLOBAL AI IN ONCOLOGY MARKET ANALYSIS BY GEOGRAPHY

  • 9.1. Regional Outlook
  • 9.2. Introduction
  • 9.3. North America Sales Analysis
    • 9.3.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.3.2. North America By Segment Sales Analysis
    • 9.3.3. North America By Country Sales Analysis
    • 9.3.4. United State Sales Analysis
    • 9.3.5. Canada Sales Analysis
    • 9.3.6. Mexico Sales Analysis
  • 9.4. Europe Sales Analysis
    • 9.4.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.4.2. Europe by Segment Sales Analysis
    • 9.4.3. Europe by Country Sales Analysis
    • 9.4.4. United Kingdom Sales Analysis
    • 9.4.5. France Sales Analysis
    • 9.4.6. Germany Sales Analysis
    • 9.4.7. Italy Sales Analysis
    • 9.4.8. Russia Sales Analysis
    • 9.4.9. Rest Of Europe Sales Analysis
  • 9.5. Asia Pacific Sales Analysis
    • 9.5.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.5.2. Asia Pacific by Segment Sales Analysis
    • 9.5.3. Asia Pacific by Country Sales Analysis
    • 9.5.4. China Sales Analysis
    • 9.5.5. India Sales Analysis
    • 9.5.6. Japan Sales Analysis
    • 9.5.7. South Korea Sales Analysis
    • 9.5.8. Australia Sales Analysis
    • 9.5.9. South East Asia Sales Analysis
    • 9.5.10. Rest Of Asia Pacific Sales Analysis
  • 9.6. Latin America Sales Analysis
    • 9.6.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.6.2. Latin America by Segment Sales Analysis
    • 9.6.3. Latin America by Country Sales Analysis
    • 9.6.4. Brazil Sales Analysis
    • 9.6.5. Argentina Sales Analysis
    • 9.6.6. Peru Sales Analysis
    • 9.6.7. Chile Sales Analysis
    • 9.6.8. Rest of Latin America Sales Analysis
  • 9.7. Middle East & Africa Sales Analysis
    • 9.7.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.7.2. Middle East & Africa by Segment Sales Analysis
    • 9.7.3. Middle East & Africa by Country Sales Analysis
    • 9.7.4. Saudi Arabia Sales Analysis
    • 9.7.5. UAE Sales Analysis
    • 9.7.6. Israel Sales Analysis
    • 9.7.7. South Africa Sales Analysis
    • 9.7.8. Rest Of Middle East And Africa Sales Analysis

10 . COMPETITIVE LANDSCAPE OF THE AI IN ONCOLOGY COMPANIES

  • 10.1. Ai In Oncology Market Competition
  • 10.2. Partnership/Collaboration/Agreement
  • 10.3. Merger And Acquisitions
  • 10.4. New Product Launch
  • 10.5. Other Developments

11 . COMPANY PROFILES OF AI IN ONCOLOGY INDUSTRY

  • 11.1. Company Share Analysis
  • 11.2. Market Concentration Rate
  • 11.3. Azra AI
    • 11.3.1. Company Overview
    • 11.3.2. Company Revenue
    • 11.3.3. Products
    • 11.3.4. Recent Developments
  • 11.4. IBM
    • 11.4.1. Company Overview
    • 11.4.2. Company Revenue
    • 11.4.3. Products
    • 11.4.4. Recent Developments
  • 11.5. Siemens Healthcare GmbH
    • 11.5.1. Company Overview
    • 11.5.2. Company Revenue
    • 11.5.3. Products
    • 11.5.4. Recent Developments
  • 11.6. Intel Corporation
    • 11.6.1. Company Overview
    • 11.6.2. Company Revenue
    • 11.6.3. Products
    • 11.6.4. Recent Developments
  • 11.7. GE HealthCare
    • 11.7.1. Company Overview
    • 11.7.2. Company Revenue
    • 11.7.3. Products
    • 11.7.4. Recent Developments
  • 11.8. Nvidia Corporation
    • 11.8.1. Company Overview
    • 11.8.2. Company Revenue
    • 11.8.3. Products
    • 11.8.4. Recent Developments
  • 11.9. Digital Diagnostics Inc.
    • 11.9.1. Company Overview
    • 11.9.2. Company Revenue
    • 11.9.3. Products
    • 11.9.4. Recent Developments
  • 11.10. ConcertAI
    • 11.10.1. Company Overview
    • 11.10.2. Company Revenue
    • 11.10.3. Products
    • 11.10.4. Recent Developments
  • 11.11. Median Technologies
    • 11.11.1. Company Overview
    • 11.11.2. Company Revenue
    • 11.11.3. Products
    • 11.11.4. Recent Developments
  • 11.12. PathAI
    • 11.12.1. Company Overview
    • 11.12.2. Company Revenue
    • 11.12.3. Products
    • 11.12.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Analysis by Component Type (USD MN)
  • Software Solutions Market Sales by Geography (USD MN)
  • Hardware Market Sales by Geography (USD MN)
  • Services Market Sales by Geography (USD MN)
  • Analysis Market by Cancer Type (USD MN)
  • Breast Cancer Market Sales by Geography (USD MN)
  • Lung Cancer Market Sales by Geography (USD MN)
  • Prostate Cancer Market Sales by Geography (USD MN)
  • Colorectal Cancer Market Sales by Geography (USD MN)
  • Brain Tumor Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Analysis by Application (USD MN)
  • Diagnostics (Pathology, Cancer Radiology) Market Sales by Geography (USD MN)
  • Radiation Therapy (Radiotherapy) Market Sales by Geography (USD MN)
  • Research & Development (Drug Design, Development Process, etc.) Market Sales by Geography (USD MN)
  • Chemotherapy Market Sales by Geography (USD MN)
  • Immunotherapy Market Sales by Geography (USD MN)
  • Analysis by End-use Type (USD MN)
  • Hospitals Market Sales by Geography (USD MN)
  • Surgical Centers & Medical Institutes Market Sales by Geography (USD MN)
  • Others (Pharmaceutical Companies, Research Institutes & Training Centers) Market Sales by Geography (USD MN)
  • Global Ai In Oncology Market Sales by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Ai In Oncology Report
  • Market Research Process
  • Market Research Methodology
  • Global Ai In Oncology Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Component Type
  • Market Attractiveness Analysis by Cancer Type
  • Market Attractiveness Analysis by Application
  • Market Attractiveness Analysis by End-use Type
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Component Type (USD MN)
  • Software Solutions Market Sales by Geography (USD MN)
  • Hardware Market Sales by Geography (USD MN)
  • Services Market Sales by Geography (USD MN)
  • Global Market Analysis by Cancer Type (USD MN)
  • Breast Cancer Market Sales by Geography (USD MN)
  • Lung Cancer Market Sales by Geography (USD MN)
  • Prostate Cancer Market Sales by Geography (USD MN)
  • Colorectal Cancer Market Sales by Geography (USD MN)
  • Brain Tumor Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market Analysis by Application (USD MN)
  • Diagnostics (Pathology, Cancer Radiology) Market Sales by Geography (USD MN)
  • Radiation Therapy (Radiotherapy) Market Sales by Geography (USD MN)
  • Research & Development (Drug Design, Development Process, etc.) Market Sales by Geography (USD MN)
  • Chemotherapy Market Sales by Geography (USD MN)
  • Immunotherapy Market Sales by Geography (USD MN)
  • Global Market Analysis by End-use Type (USD MN)
  • Hospitals Market Sales by Geography (USD MN)
  • Surgical Centers & Medical Institutes Market Sales by Geography (USD MN)
  • Others (Pharmaceutical Companies, Research Institutes & Training Centers) Market Sales by Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.